Transfusion-related acute lung injury: definition and review.

BACKGROUND Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-associated mortality, even though it is probably still underdiagnosed and underreported. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE ACTION The National Heart, Lung, and Blood Institute convened a working group to identify areas of research needed in TRALI. The working group identified the immediate need for a common definition and thus developed the clinical definition in this report. MAJOR CONCEPTS IN THE DEFINITION The major concept is that TRALI is defined as new acute lung injury occurring during or within 6 hrs after a transfusion, with a clear temporal relationship to the transfusion. Also, another important concept is that acute lung injury temporally associated with multiple transfusions can be TRALI, because each unit of blood or blood component can carry one or more of the possible causative agents: antileukocyte antibody, biologically active substances, and other yet unidentified agents. RECOMMENDATION Using the definition in this report, clinicians can diagnose and report TRALI cases to the blood bank; importantly, researchers can use this definition to determine incidence, pathophysiology, and strategies to prevent this leading cause of transfusion-associated mortality.

[1]  C. Silliman,et al.  Transfusion-related acute lung injury. , 2005, Blood.

[2]  C. Silliman,et al.  Compounds biologically similar to platelet activating factor are present in stored blood components , 1993, Lipids.

[3]  O. Gajic,et al.  Transfusion-related acute lung injury. , 2004, Mayo Clinic proceedings.

[4]  M. Blajchman,et al.  Transfusion-related acute lung injury. , 2003, Transfusion medicine reviews.

[5]  M. Nakagawa,et al.  Acute and transient decrease in neutrophil count in transfusion‐related acute lung injury: cases at one hospital , 2004, Transfusion.

[6]  M. Nakagawa,et al.  Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion‐related acute lung injury , 2004, Transfusion.

[7]  J. S. St. Sauver,et al.  Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation* , 2004, Critical care medicine.

[8]  M. Matthay,et al.  Transfusion-related acute lung injury: a review. , 2004, Chest.

[9]  M. Yazer,et al.  The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC , 2004, Transfusion.

[10]  D. Christiani,et al.  Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. , 2004, Chest.

[11]  U. Sachs,et al.  TRALI after the transfusion of cross‐match‐positive granulocytes , 2003, Transfusion.

[12]  C. Ogilvy,et al.  Transfusion-related acute lung injury or acute chest syndrome of sickle cell disease? — A case report , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[13]  C. Chapman,et al.  Single hospital experience of TRALI , 2003, Transfusion.

[14]  D. Thangathurai,et al.  TRALI and massive transfusion. , 2003, Resuscitation.

[15]  N. Voelkel,et al.  Plasma and lipids from stored platelets cause acute lung injury in an animal model , 2003, Transfusion.

[16]  J. Wallis.  Transfusion-related acute lung injury (TRALI)--under-diagnosed and under-reported. , 2003, British journal of anaesthesia.

[17]  C. Silliman,et al.  Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. , 2003, Blood.

[18]  L. Williamson.  Transfusion hazard reporting: powerful data, but do we know how best to use it? , 2002, Transfusion.

[19]  P. Holland,et al.  Transfusion-related acute lung injury: report of a clinical look-back investigation. , 2002, JAMA.

[20]  M. Matthay,et al.  Etiology of acute pulmonary edema during liver transplantation : a series of cases with analysis of the edema fluid. , 2001, Chest.

[21]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[22]  J. Muir,et al.  Une cause rare d'hémorragie intra-alvéolaire: l'accident transfusionnel avec leucoagglutination par anticorps antigranuleux (syndrome Trali) , 1998 .

[23]  A. Cuvelier,et al.  [A rare cause of intra-alveolar hemorrhage: a transfusion-related incident with leukoagglutination due to antigranulocyte antibodies (Trali syndrome)]. , 1998, La Revue de medecine interne.

[24]  N. Voelkel,et al.  Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. , 1998, The Journal of clinical investigation.

[25]  A. Paterson,et al.  The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective study , 1997, Transfusion.

[26]  C. Silliman,et al.  Analysis of the priming activity of lipids generated during routine storage of platelet concentrates , 1996, Transfusion.

[27]  R. Maunder,et al.  Clinical risks for development of the acute respiratory distress syndrome. , 1995, American journal of respiratory and critical care medicine.

[28]  C. Silliman,et al.  Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. , 1994, The Journal of laboratory and clinical medicine.

[29]  M. Lamy,et al.  Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. , 1994, Journal of critical care.

[30]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[31]  F. Schildberg,et al.  Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery , 1993, The Lancet.

[32]  C. Silliman,et al.  Stored Blood Components Contain Agents That Prime the Neutrophil NADPH Oxidase through the Platelet‐Activating‐Factor Receptor , 1992, Vox sanguinis.

[33]  P. Tartter,et al.  Postoperative infections following autologous and homologous blood transfusions , 1992, Transfusion.

[34]  W. Seeger,et al.  Reproduction of transfusion-related acute lung injury in an ex vivo lung model. , 1990, Blood.

[35]  D. Hurd,et al.  Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. , 1986, Blood.

[36]  S. Moore,et al.  Diagnostic and pathogenetic considerations in transfusion‐related acute lung injury , 1985, Transfusion.

[37]  T. Petty,et al.  Adult respiratory distress syndrome: risk with common predispositions. , 1983, Annals of internal medicine.

[38]  P. Pepe,et al.  Clinical predictors of the adult respiratory distress syndrome. , 1982, American journal of surgery.

[39]  S. Thomas,et al.  Fulminating noncardiogenic pulmonary edema. A newly recognized hazard during cardiac operations. , 1980, The Journal of thoracic and cardiovascular surgery.

[40]  D. Heimbach,et al.  Effect of micropore filtration on pulmonary function after massive transfusion. , 1980, American journal of surgery.

[41]  E. Habermann,et al.  An in vivo evaluation of microaggregate blood filtration during total hip replacement. , 1980, Annals of surgery.

[42]  E. Habermann,et al.  An in Vivo Evaluation of Micro aggregate Blood Filtration During Total Hip Replacement , 1979 .

[43]  J. Murray,et al.  The value of edema fluid protein measurement in patients with pulmonary edema. , 1979, The American journal of medicine.

[44]  C. Zmijewski,et al.  Transfusion reaction with pulmonary infiltration associated with HL-A-specific leukocyte antibodies. , 1976, American journal of clinical pathology.

[45]  G. Geelhoed,et al.  "Shock lung" resulting from perfusion of canine lungs with stored bank blood. , 1975, The American surgeon.

[46]  M. Parmely,et al.  Pulmonary "hypersensitivity" reactions induced by transfusion of non-HL-A leukoagglutinins. , 1971, The New England journal of medicine.

[47]  H. N. Ward.  Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. , 1970, Annals of internal medicine.

[48]  F. Fleischner,et al.  Pulomonary edema in the course of a blood transfusion without overloading the circulation. , 1966, Diseases of the chest.

[49]  T. E. Brittingham,et al.  Immunologic Studies on Leukocytes * , 1957, Vox sanguinis.

[50]  R. Barnard,et al.  Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. , 1951, New York state journal of medicine.